Exosomal circRNA: emerging insights into cancer progression and clinical application potential

F Zhang, J Jiang, H Qian, Y Yan, W Xu - Journal of Hematology & …, 2023 - Springer
Exosomal circRNA serves a novel genetic information molecule, facilitating communication
between tumor cells and microenvironmental cells, such as immune cells, fibroblasts, and …

Exosomal circular RNAs: a chief culprit in cancer chemotherapy resistance

X Guo, C Gao, DH Yang, S Li - Drug Resistance Updates, 2023 - Elsevier
Chemotherapy is one of the primary treatments for malignant tumors. However, the acquired
drug resistance hinders clinical efficacy and leads to treatment failure in most patients …

Modulating glycolysis to improve cancer therapy

C Chelakkot, VS Chelakkot, Y Shin, K Song - International Journal of …, 2023 - mdpi.com
Cancer cells undergo metabolic reprogramming and switch to a 'glycolysis-
dominant'metabolic profile to promote their survival and meet their requirements for energy …

Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment

J Li, L Zhu, HF Kwok - Drug Resistance Updates, 2023 - Elsevier
Lung cancer continues to be a malignant tumor with high mortality. Two obstacles interfere
with curative therapy of lung cancer:(i) poor diagnosis at the early stages, as symptoms are …

Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy

C Xiao, H Tian, Y Zheng, Z Yang, S Li, T Fan… - Frontiers in Cell and …, 2022 - frontiersin.org
Cancer cells and immune cells all undergo remarkably metabolic reprogramming during the
oncogenesis and tumor immunogenic killing processes. The increased dependency on …

The dual role of citrate in cancer

P Icard, L Simula, G Zahn, M Alifano… - Biochimica et Biophysica …, 2023 - Elsevier
Citrate is a key metabolite of the Krebs cycle that can also be exported in the cytosol, where
it performs several functions. In normal cells, citrate sustains protein acetylation, lipid …

Flubendazole enhances the inhibitory effect of paclitaxel via HIF1α/PI3K/AKT signaling pathways in breast cancer

Y Zhou, M Liao, Z Li, J Ye, L Wu, Y Mou, L Fu… - International Journal of …, 2023 - mdpi.com
Paclitaxel, a natural anticancer drug, is widely recognized and extensively utilized in the
treatment of breast cancer (BC). However, it may lead to certain side effects or drug …

The Ubiquitin–Proteasome System in Tumor Metabolism

J Wang, Y Xiang, M Fan, S Fang, Q Hua - Cancers, 2023 - mdpi.com
Simple Summary The reprogramming of tumor cell metabolism is an important char acteristic
of cancer, which provides the energy and biomacromolecules in tumor development …

COPS3 inhibition promotes cell proliferation blockage and anoikis via regulating PFKFB3 in osteosarcoma cancer cells

F Zhang, Q Li, Y Zhang, N Li, M Rao, S Li, Z Ai… - European Journal of …, 2023 - Elsevier
As a key component of the COP9 signalosome complex, which participates in a variety of
physiological processes, COPS3 is intimately related to multiple cancers. It promotes cell …

Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway

M Li, Z Liu, Z Hou, X Wang, H Shi, Y Li, X Xiao… - Thoracic …, 2023 - Wiley Online Library
Background Zinc finger protein 687 (ZNF687) has previously been discovered as a potential
oncogene in individuals with giant cell tumors of the bone, acute myeloid leukemia, and …